Transapical aortic valve implantation (TA-AVI) is a new therapeutic strategy, which has been implemented successfully into clinical practice in several hundred patients suffering symptomatic aortic stenosis and an increase perioperative risk during the past two years. The Edwards SAPIEN™ prosthesis has been used. Read more ...
- In competitive athletes >35 years of age with a high-risk profile for future cardiovascular events, an exercise test is mandatory to rule out/confirm the presence of (silent) underlying ischemic heart disease - For recreational sports/leisure-time activity, the exercise Read more ...
Replacing heart valves without the substantial trauma of opening the chest and the heart were little known concepts until the groundbreaking pulmonary and aortic transcatheter valve replacements performed during 2000 and 2002, respectively by Philipp Bonhoeffer and Alain Cribier. Read more ...
The results of a new observational study presented recently at the showed that patients who stop taking their prescribed statins have a four-fold increased risk of death during the first year following an acute coronary syndrome. The study included 2,234 patients who were prescribed statin therapy after an acute coronary syndrome. Patients were followed for one year after discharge from the hospital. Read more ...
The issue of using or not using DES in patients with diabetes will be debated between Professor Wijns, who discourages DES and Professor Silber, who feels that they should be used. Diabetes is increasingly viewed as a coronary artery disease equivalent. Read more ...
The LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) Study randomly assigned 1,707 patients with 2,472 lesions to treatment with either a biolimus-eluting stent with a biodegradable polymer or a sirolimus-eluting stent with a durable polymer. The study involved a broad range of patients for whom a stenting procedure was considered suitable, designed to reflect routine clinical practice. Read more ...
Boston Scientific Corporation (NYSE: BSX) announced one-year data from its landmark SYNTAX trial comparing percutaneous coronary intervention (PCI) using the TAXUS® Express2™ Paclitaxel-Eluting Coronary Stent System to contemporary coronary artery bypass graft (CABG) surgery. The overall results demonstrated no statistically significant differences between PCI and CABG in rates of death or myocardial infarction (MI). Read more ...
Subscribe to:
Post Comments (Atom)
1 comments:
Hello Blog admin,Thank you for this great opportunity to write on your blog regarding a wonderful deed of a traditional healer called Dr Itua which helped me cure my myeloma cancer and diabetes,Arthritis, At the same time I was devastated from living a helpless life until I came across Dr Itua herbal center.Dr Itua is a traditional herbal doctor who reside in africa and he have so many knowledge about natural root and herbs to cure all kind of disease and infections, Dr Itua has really been so good to me and my family in time of herbal remedies so I will advise anyone here with health challenge to contact Dr Itua for help to get healed from all kind of diseases.Contact Dr Itua herbal center on:
drituaherbalcenter@gmail.com / https://drituaherbalcenter.com
Post a Comment